How much does Daklinza cost?

Q: How much does Daklinza cost?

When Daklinza was on the market, the wholesale cost for a 12-week course was roughly $63,000, but patients paid a range of $72,000 to $75,000. Daklinza was discontinued by Bristol Myers Squibb in 2019 due to business reasons.

Medically reviewed by Leigh Ann Anderson, PharmD. Last updated on Feb 19, 2025.

Official Answer by Drugs.com

When Daklinza (daclatasvir) was on the market, the wholesale cost for a 12-week course was roughly $63,000, but patients paid a range of $72,000 to $75,000. Daklinza and the generic daclatasvir was discontinued by Bristol Myers Squibb in 2019 due to business reasons.

Daklinza (daclatasvir) was formerly approved for the treatment of chronic hepatitis C virus (HCV) in adults, in combination with sofosbuvir (brand name: Sovaldi), with or without ribavirin, in genotypes 1 and 3, including hard to treat HCV patients such as those with HIV-1 co-infection, advanced cirrhosis, or post-liver transplant recurrence of HCV.

Daklinza is classified as a HCV NS5A inhibitor.

References

Important information about the discontinuation of Daklinza. Bristol Myers Squibb. Accessed March 1, 2021 at https://www.bms.com/patient-and-caregivers/our-medicines/discontinuation-of-daklinza.html

How much does Daklinza cost?

See also:

Aimovig

Nurtec ODT

Botox

Vyepti

Depakote

Topamax

Emgality

Inderal

Ajovy

Valproate Sodium

Related medical questions

Drug information

Related support groups